Self-Adjuvanted Nanoparticles as an HIV Vaccine Platform

作为 HIV 疫苗平台的自佐纳米颗粒

• 批准号: 376546
• 负责人: Sicard Taylor
• 金额: $ 10.93万
• 依托单位: University of Toronto
• 依托单位国家: 加拿大
• 项目类别: Studentship Programs
• 财政年份: 2017
• 资助国家: 加拿大
• 起止时间: 2017-11-01 至 2020-11-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=376546&lang=en
• 关键词: B Cells; Hiv; Protein Engineering; Self-Assembling Nanoparticles; Vaccines

Over the past 25 years, efforts have failed to develop a vaccine capable of broadly protecting against HIV. In response to HIV, the human immune system seems generally unable to respond effectively, providing limited protection to the infected individual.

过去 25 年来，人们一直未能开发出能够广泛预防艾滋病毒的疫苗。针对艾滋病毒，人类免疫系统似乎通常无法有效应对，只能为感染者提供有限的保护。